Literature DB >> 1328252

The significance of determining CA 15-3 in the cytosol of breast cancer.

K Kosian1, C Bieglmayer, W Neunteufel, C Dadak.   

Abstract

The identification of tumor markers in patients who had undergone operation for breast cancer provides important information in the follow-up in addition to evaluation by clinical and visual methods. The aim of our study was to determine the clinical prospective value of CA 15-3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in preoperative measurement of serum samples in patients with primary breast cancer, and to determine CA 15-3 and steroid receptors in the cytosol of the tumor. The results show that the most exact correlation occurred between serum CA 15-3 and the different stages of the tumor. However, there is no conclusive evidence for the prognosis and the course of the disease from preoperative findings of tumor markers in serum samples or in the cytosol of the tumor in patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328252     DOI: 10.1007/bf01209490

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer.

Authors:  D Y Wang; R A Bulbrook; J L Hayward; J C Hendrick; P Franchimont
Journal:  Eur J Cancer       Date:  1975-09       Impact factor: 9.162

2.  Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.

Authors:  D C Tormey; T P Waalkes; J J Snyder; R M Simon
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.

Authors:  D F Hayes; V R Zurawski; D W Kufe
Journal:  J Clin Oncol       Date:  1986-10       Impact factor: 44.544

4.  Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.

Authors:  C Bieglmayer; T Szepesi; W Neunteufel
Journal:  Cancer Lett       Date:  1988-11       Impact factor: 8.679

5.  Evaluation of CA15/3 serum levels in breast cancer patients.

Authors:  M Gion; R Mione; R Dittadi; S Fasan; A Pallini; G Bruscagnin
Journal:  J Nucl Med Allied Sci       Date:  1986 Jan-Mar

6.  Clinical correlation between CEA and breast cancer.

Authors:  D C Tormey; T P Waalkes
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

7.  Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.

Authors:  M Gion; R Mione; R Dittadi; S Fasan; A Pallini; G Bruscagnin
Journal:  Cancer       Date:  1986-03-01       Impact factor: 6.860

8.  The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas.

Authors:  M J Wilkinson; A Howell; M Harris; J Taylor-Papadimitriou; R Swindell; R A Sellwood
Journal:  Int J Cancer       Date:  1984-03-15       Impact factor: 7.396

9.  Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.

Authors:  N Fujino; Y Haga; K Sakamoto; H Egami; M Kimura; R Nishimura; M Akagi
Journal:  Jpn J Clin Oncol       Date:  1986-12       Impact factor: 3.019

10.  Value of CA 15:3 in the follow-up of breast cancer patients.

Authors:  D M Pons-Anicet; B P Krebs; R Mira; M Namer
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.